Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders

Molecular Psychiatry

Volumn 21, Issue 3, 2016, Pages 376-385

  Kim, S ^a   Hwang, Y ^b   Webster, M J ^a   Lee, D ^b  

^a Stanley Medical Research Institute   (United States)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; COMPLEMENT COMPONENT C1; CXCL13 CHEMOKINE; GLUTAMATE DECARBOXYLASE 1; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN 6; INTERLEUKIN 10; INTERLEUKIN 23 RECEPTOR; PARVALBUMIN; PROTEIN; RIBOSOME RNA; SEROTONIN 2A RECEPTOR; SMALL NUCLEAR RNA; SYNAPTOSOMAL ASSOCIATED PROTEIN25; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; MESSENGER RNA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BIPOLAR DISORDER; CELL MIGRATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DENTATE GYRUS; GABAERGIC SYSTEM; GENE EXPRESSION; GENE INTERACTION; GLIA CELL; HIPPOCAMPUS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTERNEURON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN PROCESSING; RIBOSOME; RNA PROCESSING; RNA SEQUENCE; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; FACTUAL DATABASE; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGY; MALE; MENTAL DISEASE; METABOLISM; MOOD DISORDER; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HUMANS; MALE; MENTAL DISORDERS; MOOD DISORDERS; PARVALBUMINS; RECEPTOR, SEROTONIN, 5-HT2A; RETROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 84958880509     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.79     Document Type: Article

References (60)

1. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593-624.
2. Vawter MP, Freed WJ, Kleinman JE. Neuropathology of bipolar disorder. Biol Psychiatry 2000; 48: 486-504.
3. Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200-206.
4. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 2001; 12: 3257-3262.
5. Eastwood SL, Harrison PJ. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 2000; 5: 425-432.
6. Eastwood SL, Harrison PJ. Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008; 33: 933-945.
7. Focking M, Dicker P, English JA, Schubert KO, Dunn MJ, Cotter DR. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry 2011; 68: 477-488.
8. Zhang ZJ, Reynolds GP. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 2002; 55: 1-10.
9. Fatemi SH, Earle JA, McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000; 5: 654-663571.
10. Thompson Ray M, Weickert CS, Wyatt E, Webster MJ. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 2011; 36: 195-203.
11. Vawter MP, Hemperly JJ, Hyde TM, Bachus SE, VanderPutten DM, Howard AL., et al. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia. Exp Neurol 1998; 154: 1-11.
12. Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull 2006; 70: 221-227.
13. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000; 44: 151-155.
14. Kim S, Webster MJ. The Stanley Neuropathology Consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010; 35: 473-482.
15. Kim S, Webster MJ. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 2010; 15: 326-336.
16. Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001; 55: 651-659.
17. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004; 9: 609-620544.
18. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 2005; 57: 252-260.
19. Hwang Y, Kim J, Shin JY, Kim JI, Seo JS, Webster MJ., et al. Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammationrelated genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry 2013; 3: e321.
20. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25: 1105-1111.
21. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26: 139-140.
22. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform 2008; 9: 559.
23. Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 2007; 3: 1724-1735.
24. Hu Z, Mellor J, Wu J, DeLisi C. VisANT: an online visualization and analysis tool for biological interaction data. BMC Bioinform 2004; 5: 17.
25. Langfelder P, Luo R. Oldham MC, Horvath S. Is my network module preserved and reproducible?. PLoS Comp Biol 2011; 7: e1001057.
26. Kim S, Cho H, Lee D, Webster MJ. Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry 2012; 2: e113.
27. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118-127.
28. Dennis G Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
29. DeCarolis NA, Eisch AJ. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology 2010; 58: 884-893.
30. Sun X, Wang JF, Tseng M, Young LT. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 2006; 31: 189-196.
31. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004; 61: 300-308.
32. Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 2006; 11: 241-251.
33. Nakatani N, Hattori E, Ohnishi T, Dean B, Iwayama Y, Matsumoto I., et al. Genomewide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet 2006; 15: 1949-1962.
34. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006; 11: 965-978.
35. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V., et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PloS One 2009; 4: e6585.
36. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP., et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653-15658.
37. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798-805.
38. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005; 10: 309-322.
39. Akula N, Barb J, Jiang X, Wendland JR, Choi KH, Sen SK., et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry 2014; 19: 1179-1185.
40. Torkamani A, Dean B, Schork NJ, Thomas EA. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res 2010; 20: 403-412.
41. Gaiteri C, Sibille E. Differentially expressed genes in major depression reside on the periphery of resilient gene coexpression networks. Front Neurosci 2011; 5: 95.
42. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S., et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011; 474: 380-384.
43. Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V. A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry 2012; 69: 1205-1213.
44. Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA., et al. Two gene coexpression modules differentiate psychotics and controls. Mol Psychiatry 2013; 18: 1308-1314.
45. Mistry M, Gillis J, Pavlidis P. Meta-Analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci 2013; 14: 105.
46. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 2012; 28: 882-883.
47. Mostafavi S, Battle A, Zhu X, Urban AE, Levinson D, Montgomery SB., et al. Normalizing RNA-sequencing data by modeling hidden covariates with prior knowledge. PloS One 2013; 8: e68141.
48. Rydmark I, Wahlberg K, Ghatan PH, Modell S, Nygren A, Ingvar M., et al. Neuroendocrine, cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression. Biol Psychiatry 2006; 60: 867-873.
49. Radulovic J, Ruhmann A, Liepold T, Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 1999; 19: 5016-5025.
50. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ., et al. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463.
51. Liu Y, Yu JT, Zhang W, Zong Y, Lu RC, Zhou J., et al. Interleukin-23 receptor polymorphisms are associated with Alzheimer's disease in Han Chinese. J Neuroimmunol 2014; 271: 43-48.
52. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007; 131: 1164-1178.
53. Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P., et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 2012; 18: 1413-1417.
54. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T., et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 2008; 13: 717-728.
55. Faust D, Loos M. In vitro modulation of C1q mRNA expression and secretion by interleukin-1, interleukin-6, and interferon-gamma in resident and stimulated murine peritoneal macrophages. Immunobiology 2002; 206: 368-376.
56. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008; 18: 1509-1517.
57. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10: 57-63.
58. Al-Amin MM, Nasir Uddin MM, Mahmud Reza H. Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci 2013; 11: 144-151.
59. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-Analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011; 70: 663-671.
60. Tourjman V, Kouassi E, Koue ME, Rocchetti M, Fortin-Fournier S, Fusar-Poli P., et al. Antipsychotics' effects on blood levels of cytokines in schizophrenia: a metaanalysis. Schizophr Res 2013; 151: 43-47.